We are live on ! Find out more
PHK

Point72 Hong Kong Portfolio holdings

AUM $2.18B
1-Year Est. Return 89.02%
This Fund
S&P 500
This Quarter Est. Return
+31.02%
1 Year Est. Return
+89.02%
3 Year Est. Return
+396.1%
5 Year Est. Return
+490.26%
10 Year Est. Return
+2,256.88%
AUM
$898M
AUM Growth
+$671M
Cap. Flow
+$577M
Cap. Flow %
64.25%
Top 10 Hldgs %
24.01%
Holding
1,562
New
650
Increased
364
Reduced
95
Closed
448

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.84%
2 Technology 16.34%
3 Financials 10.65%
4 Consumer Staples 9.79%
5 Communication Services 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGYS icon
1001
Agilysys
AGYS
$3.06B
$8K ﹤0.01%
427
-1,575
-79% -$29.5K
ALGT icon
1002
Allegiant Air
ALGT
$2.57B
$8K ﹤0.01%
72
+57
+380% +$5.21K
CCRN
1003
DELISTED
Cross Country Healthcare
CCRN
$8K ﹤0.01%
+1,330
New +$8.16K
CNS icon
1004
Cohen & Steers
CNS
$4.3B
$8K ﹤0.01%
+121
New +$7.29K
HBNC icon
1005
Horizon Bancorp
HBNC
$1.04B
$8K ﹤0.01%
+752
New +$7.67K
OSUR icon
1006
OraSure Technologies
OSUR
$279M
$8K ﹤0.01%
+671
New +$8.71K
RES icon
1007
RPC Inc
RES
$1.3B
$8K ﹤0.01%
+2,635
New +$8.02K
NAGE
1008
Niagen Bioscience
NAGE
$247M
$8K ﹤0.01%
+1,835
New +$8.21K
KRTX
1009
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$8K ﹤0.01%
+75
New +$6.52K
USWS
1010
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$8K ﹤0.01%
+806
New +$8.01K
ALLO icon
1011
Allogene Therapeutics
ALLO
$694M
$7K ﹤0.01%
+162
New +$5.86K
AOSL icon
1012
Alpha and Omega Semiconductor
AOSL
$1.08B
$7K ﹤0.01%
+682
New +$6.99K
DAKT icon
1013
Daktronics
DAKT
$1.04B
$7K ﹤0.01%
+1,546
New +$6.83K
GME icon
1014
GameStop
GME
$8.6B
$7K ﹤0.01%
6,584
-148
-2% -$171
KRYS icon
1015
Krystal Biotech
KRYS
$9.66B
$7K ﹤0.01%
+172
New +$8.28K
OCUL icon
1016
Ocular Therapeutix
OCUL
$2.02B
$7K ﹤0.01%
+898
New +$5.95K
OZK icon
1017
Bank OZK
OZK
$5.61B
$7K ﹤0.01%
+290
New +$6.22K
VCEL icon
1018
Vericel Corp
VCEL
$2.31B
$7K ﹤0.01%
533
-1,514
-74% -$20.5K
VNDA icon
1019
Vanda Pharmaceuticals
VNDA
$302M
$7K ﹤0.01%
593
-471
-44% -$5.33K
HZNP
1020
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7K ﹤0.01%
130
-2,410
-95% -$103K
AMSF icon
1021
AMERISAFE
AMSF
$540M
$6K ﹤0.01%
+98
New +$6.1K
BPMC
1022
DELISTED
Blueprint Medicines
BPMC
$6K ﹤0.01%
71
-352
-83% -$23.8K
CHEF icon
1023
Chefs' Warehouse
CHEF
$4.5B
$6K ﹤0.01%
+453
New +$6.25K
CODX
1024
Co-Diagnostics
CODX
$5.6M
$6K ﹤0.01%
+10
New +$4.56K
EOLS icon
1025
Evolus
EOLS
$501M
$6K ﹤0.01%
1,089
-1,190
-52% -$5.48K

Similar funds

Point72 Hong Kong's Q2 2020 Portfolio in Review

As of Q2 2020, Point72 Hong Kong held 1,562 positions worth $898M, up 296% from $227M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Point72 Hong Kong deployed $577M of net new capital in Q2 2020, opening 650 new positions and adding to 364 existing holdings. Its largest new stake was Wynn Resorts: 218,220 shares worth $16.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $6.76M trimmed.

  • Point72 Hong Kong's largest Q2 2020 buy was Wynn Resorts: 218,220 shares worth $16.3M.
  • Point72 Hong Kong added most to GDS Holdings in Q2 2020, an estimated $12.1M increase.
  • Point72 Hong Kong's biggest Q2 2020 reduction was Microsoft, cutting an estimated $6.76M.
  • Point72 Hong Kong fully exited State Street SPDR S&P 500 ETF Trust in Q2 2020, selling an estimated $15.7M.
  • Point72 Hong Kong's ten largest holdings make up 24% of its $898M portfolio in Q2 2020.
  • Point72 Hong Kong opened 650 new positions and closed 448 in Q2 2020.
  • Point72 Hong Kong's portfolio value rose 296% quarter-over-quarter to $898M.

Based on Point72 Hong Kong's 13F filing for Q2 2020, filed 14 Aug 2020.